FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1418211000001104: Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24197901000001115 Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41215301000001118 Zileze 7.5 tablets (Opus Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 4 (CD Benz) true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Is a Zopiclone 7.5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Is pack of Zileze 7.5 tablets (Opus Pharmaceuticals) false Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has active ingredient Zopiclone false Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has AMP Zileze 7.5 tablets (Opus Pharmaceuticals) true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has specific active ingredient Zopiclone true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Zileze 7.5 tablets (Opus Pharmaceuticals) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start